' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

HUBER-CANTONATI PETRA
Universitätsinstitut für Pharmazie

Publikationen

5 Publikationen

2019

Beiträge in Fachzeitschriften

Inhibition of Cyclin-Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy.
Ardelt, MA; Fröhlich, T; Martini, E; Müller, M; Kanitz, V; Atzberger, C; Cantonati, P; Meßner, M; Posselt, L; Lehr, T; Wojtyniak, JG; Ulrich, M; Arnold, GJ; König, L; Parazzoli, D; Zahler, S; Rothenfußer, S; Mayr, D; Gerbes, A; Scita, G; Vollmar, AM; Pachmayr, J;
Hepatology. 2019; 69(1):376-393
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Cdk5 Inhibition - The Key to Enhancing the Standard of Care in Hepatocellular Carcinoma Treatment.
Ardelt, MA; Fröhlich, T; Martini, E; Müller, M; Kanitz, V; Atzberger, C; Cantonati, P; Meßner, M; Posselt, L; Lehr, T; Wojtyniak, JG; Ulrich, M; Arnold, GJ; König, L; Parazzoli, D; Zahler, S; Rothenfußer, S; Mayr, D; Gerbes, A; Scita, G; Vollmar, AM; Pachmayr, J;
Final Programme & Book of Abstracts.. 2019; -26th Scientific Congress of the Austrian Pharmaceutical Society ; 25.-27.04.2019; Graz.
Abstracts (Zeitschrift)
Potential to improve the therapeutic situation of HCC patients - The influence of Regorafenib and Lenvatinib treatment in combination with Cdk5 inhibition in HCC.
Ardelt, MA; Huber-Cantonati, P; Pachmayr, J;
10. Paracelsus Science Get Together Abstractband 2019. 2019; -10. Paracelsus Science Get Together ; 28.06.2019; Nürnberg.
Abstracts (Zeitschrift)
Potential to improve the therapeutic situation of HCC patients - The influence of Regorafenib and Lenvatinib treatment in combination with Cdk5 inhibition in HCC.
Ardelt, MA; Huber-Cantonati, P; Pachmayr, J;
Final Programme & Book of Abstracts.. 2019; -26th Scientific Congress of the Austrian Pharmaceutical Society; 25.-27.04.2019; Graz.
Abstracts (Zeitschrift)
Diamonds in the rough - With low application Antibiotics against Tumor Relapse of sorafenib-resistant Hepatocellular Carcinoma.
Meßner, M; Zischka, H; Schmitt, S; Ardelt, MA; Huber-Cantonati, P; Fröhlich, T; Arnold, GJ; Atzberger, C; Müller, M; Pein, H; Koeberle, A; Zobel, LM; Koenig, L; Vollmair, AM; Pachmayr, J;
Final Programme & Book of Abstracts.. 2019; -26th Scientific Congress of the Austrian Pharmaceutical Society ; 25.-27.04.2019; Graz.
Abstracts (Zeitschrift)